The eye's own cleanup crew: immune cells that prevent glaucoma by keeping drainage clear

Immunity, March 9, 2026

The eye has a plumbing problem. Fluid constantly flows through the anterior chamber, and when the drainage system clogs, pressure builds. That pressure damages the optic nerve. The damage is called glaucoma, and it is the leading cause of irreversible blindness worldwide.

Every existing glaucoma treatment works the same way: lower the pressure. But none of them target the underlying cause of the clog. A study published in Immunity by researchers at Duke University may change that. The team has identified a population of immune cells that function as the eye's built-in maintenance crew, clearing debris from drainage tissues to keep fluid flowing.

Macrophages as custodians

The cells in question are resident macrophages, a type of immune cell that lives permanently in tissue rather than circulating through the bloodstream. Macrophages are known throughout the body as cellular garbage collectors, consuming dead cells, pathogens, and debris. But their role in the eye's drainage system, specifically the trabecular meshwork and Schlemm's canal, had not been established until now.

Lead author Katy Liu and her colleagues tracked fluorescently tagged macrophages in mouse eyes. When they selectively removed these cells, the results were immediate and dramatic: the drainage tissue became clogged, fluid accumulated, and intraocular pressure rose. The finding establishes a direct link between macrophage function and pressure regulation.

The mechanism appears straightforward. The drainage tissues accumulate cellular debris over time, and resident macrophages consume this debris to keep the channels clear. Without them, the system backs up like a drain full of hair.

Why current treatments fall short

Glaucoma affects more than 80 million people globally. Current medications lower eye pressure through various mechanisms, including reducing fluid production or increasing outflow through alternative pathways. But as Liu noted, patients continue to go blind despite these treatments. The reason is that none of the existing drugs address the root problem in the drainage tissue itself.

Understanding that resident macrophages maintain drainage function opens a fundamentally different therapeutic approach. Rather than working around a clogged drain, future treatments could potentially restore or enhance the cells that keep it clear in the first place.

Co-corresponding author W. Daniel Stamer emphasized the distinction: current medications do not target the source of disease. A therapy that supports or restores macrophage function in the drainage tissue would be the first to do so.

From mouse eyes to human questions

The study was conducted entirely in mice, and that is an important caveat. Mouse eyes and human eyes share basic anatomy but differ in significant ways, including the size and structure of the drainage system. The next critical step, which the researchers have identified as their priority, is confirming that equivalent resident macrophage populations exist in human eye tissue and perform the same function.

Even if the finding translates to humans, developing a therapy will take years. Researchers would need to understand what causes macrophage function to decline with age, whether that decline can be reversed, and what delivery method could effectively target cells in such a specific anatomical location.

The study also does not address whether macrophage dysfunction is the primary driver of all glaucoma or only certain subtypes. Glaucoma is a heterogeneous disease with multiple contributing factors, and it is possible that macrophage-based approaches would benefit some patients more than others.

A foundation, not a finish line

Duke's Eye Center has a track record in glaucoma research, including work that contributed to the first new FDA-approved glaucoma drug in 20 years. Co-corresponding author Daniel Saban described the current finding as building on that history while opening a new direction focused on the immune system's role in pressure regulation.

The study adds to a growing body of research recognizing that immune cells play regulatory roles beyond infection fighting. Resident macrophages in various tissues have been found to maintain organ function in ways that were previously unrecognized. The eye, it turns out, is no exception.